| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Regulates the Apoptosis and Survival of Glioma Cells
1 Gonda (Goldschmied) Medical Diagnosis Research Center, Faculty of Life-Sciences, Bar-Ilan University, Ramat Gan, Israel and 2 The Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan
Requests for reprints: Chaya Brodie, The Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit, MI 48202. Phone: 313-916-8619; Fax: 313-916-9855; E-mail: chaya{at}mail.biu.ac.il.
In this study, we examined the role of protein kinase C (PKC)-
in the apoptosis and survival of glioma cells using tumor necrosis factorrelated apoptosis inducing ligand (TRAIL)-stimulated cells and silencing of PKC
expression. Treatment of glioma cells with TRAIL induced activation, caspase-dependent cleavage, and down-regulation of PKC
within 3 to 5 hours of treatment. Overexpression of PKC
inhibited the apoptosis induced by TRAIL, acting downstream of caspase 8 and upstream of Bid cleavage and cytochrome c release from the mitochondria. A caspase-resistant PKC
mutant (D383A) was more protective than PKC
, suggesting that both the cleavage of PKC
and its down-regulation contributed to the apoptotic effect of TRAIL. To further study the role of PKC
in glioma cell apoptosis, we employed short interfering RNAs directed against the mRNA of PKC
and found that silencing of PKC
expression induced apoptosis of various glioma cell lines and primary glioma cultures. To delineate the molecular mechanisms involved in the apoptosis induced by silencing of PKC
, we examined the expression and phosphorylation of various apoptosis-related proteins. We found that knockdown of PKC
did not affect the expression of Bcl2 and Bax or the phosphorylation and expression of Erk1/2, c-Jun-NH2-kinase, p38, or STAT, whereas it selectively reduced the expression of AKT. Similarly, TRAIL reduced the expression of AKT in glioma cells and this decrease was abolished in cells overexpressing PKC
. Our results suggest that the cleavage of PKC
and its down-regulation play important roles in the apoptotic effect of TRAIL. Moreover, PKC
regulates AKT expression and is essential for the survival of glioma cells.
This article has been cited by other articles:
![]() |
G. K. Lonne, K. C. Masoumi, J. Lennartsson, and C. Larsson Protein Kinase C{delta} Supports Survival of MDA-MB-231 Breast Cancer Cells by Suppressing the ERK1/2 Pathway J. Biol. Chem., November 27, 2009; 284(48): 33456 - 33465. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koh, K. Sachidanandam, A. N. Stratman, A. Sacharidou, A. M. Mayo, E. A. Murphy, D. A. Cheresh, and G. E. Davis Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation J. Cell Sci., June 1, 2009; 122(11): 1812 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Steinberg Structural Basis of Protein Kinase C Isoform Function Physiol Rev, October 1, 2008; 88(4): 1341 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Kim, Y.-S. Kim, C.-H. Park, I.-Y. Chung, J.-M. Yoo, J.-G. Kim, B.-J. Lee, S.-S. Kang, G.-J. Cho, and W.-S. Choi Protein Kinase C-{delta} Mediates Neuronal Apoptosis in the Retinas of Diabetic Rats via the Akt Signaling Pathway Diabetes, August 1, 2008; 57(8): 2181 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Steinberg, O. A. Harari, E. A. Lidington, J. J. Boyle, M. Nohadani, A. M. Samarel, M. Ohba, D. O. Haskard, and J. C. Mason A Protein Kinase C{epsilon}-Anti-apoptotic Kinase Signaling Complex Protects Human Vascular Endothelial Cells against Apoptosis through Induction of Bcl-2 J. Biol. Chem., November 2, 2007; 282(44): 32288 - 32297. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Mhaidat, R. F. Thorne, X. D. Zhang, and P. Hersey Regulation of Docetaxel-Induced Apoptosis of Human Melanoma Cells by Different Isoforms of Protein Kinase C Mol. Cancer Res., October 1, 2007; 5(10): 1073 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ardehali Signaling Mechanisms in Ischemic Preconditioning: Interaction of PKC{epsilon} and MitoKATP in the Inner Membrane of Mitochondria Circ. Res., October 13, 2006; 99(8): 798 - 800. [Full Text] [PDF] |
||||
![]() |
S. G. Laychock, S. M. Sessanna, M.-H. Lin, and L. D. Mastrandrea Sphingosine 1-Phosphate Affects Cytokine-Induced Apoptosis in Rat Pancreatic Islet {beta}-Cells Endocrinology, October 1, 2006; 147(10): 4705 - 4712. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lu, J. Huang, and A. Basu Protein Kinase C{epsilon} Activates Protein Kinase B/Akt via DNA-PK to Protect against Tumor Necrosis Factor-{alpha}-induced Cell Death J. Biol. Chem., August 11, 2006; 281(32): 22799 - 22807. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mangat, T. Singal, N. S. Dhalla, and P. S. Tappia Inhibition of phospholipase C-{gamma}1 augments the decrease in cardiomyocyte viability by H2O2 Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H854 - H860. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |